appScorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Chemo Pharma Laboratories standalone net profit declines 34.21% in the June 2024 quarter
4 months ago•Business Standard
Chemo Pharma Laboratories standalone net profit rises 10.00% in the September 2021 quarter
3 years ago•Business Standard
Chemo Pharma Laboratories standalone net profit declines 62.50% in the June 2021 quarter
3 years ago•Business Standard
Chemo Pharma Laboratories reports standalone net profit of Rs 0.02 crore in the March 2021 quarter
3 years ago•Business Standard
Chemo Pharma Laboratories standalone net profit declines 42.86% in the December 2020 quarter
3 years ago•Business Standard
BRIEF-Chemo Pharma Laboratories To Consider & Appoint Bhavin Sheth As CEO - Investing.com India
3 years ago•Investing.com